Antibodies
9 October 2013
Compugen Drug Candidate Demonstrates High Effectiveness in Type I Diabetes Animal Mode8 October 2013
MorphoSys and Xencor Provide Update on Phase 1/2a Trial in CLL/SLL for MOR208 (Xmab55743 October 2013
Single-Agent Ramucirumab Significantly Improves Overall Survival In Advanced Gastric Cancer Patients3 October 2013
New TYSABRI® Data Show Earlier Treatment and Longer-Term Use Result in Significant Reductions in MS Disease Activity2 October 2013
Merrimack Pharmaceuticals Completes Enrollment of Neoadjuvant Phase 2 Study of MM-121 in HER2-Negative Breast Cancer30 September 2013
FDA Grants Genentech’s Perjeta Accelerated Approval for Use Before Surgery in People With HER2-Positive Early Stage Breast Cancer30 September 2013
Immunomedics Reports Updated Results of Labetuzumab-SN-38 in Metastatic Colorectal Cancer30 September 2013
Gliknik Enters Into Licensing Agreement With Pfizer For Drug Candidate Targeting Autoimmune Diseases30 September 2013
Cimzia® (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis28 September 2013
Genentech’s Kadcyla Helped People With Advanced HER2-Positive Breast Cancer Live Longer Without Their Disease Worsening in New Phase III Study28 September 2013
Phase 3 Trial Comparing Vectibix® (Panitumumab) to Erbitux® (Cetuximab) Meets Primary Endpoint Of Non-Inferiority Of Overall Survival27 September 2013
FDA Approves New Dosing Option for CSL Behring’s Hizentra®27 September 2013
New data for Novartis drug Lucentis® reinforces transformational efficacy and well-established safety profile across four indications26 September 2013
Data Presented at 49th EASD Annual Meeting Show Treatment with Lilly’s Investigational Dulaglutide Resulted in Improved Patient-Reported Health OutcomesNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports